Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DUDLEY, R. E.
Right arrow Articles by KESTERSON, J. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DUDLEY, R. E.
Right arrow Articles by KESTERSON, J. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

One-Month Inhalation Toxicity Study of Tulobuterol Hydrochloride in Rats and Dogs

ROBERT E. DUDLEY1, SEAN E. PATTERSON*, SAMUEL V. MACHOTKA{dagger} and JAMES W. KESTERSON2

Abbott Laboratories Abbott Park, Illinois 60064 *PACO Research Corporation 1705 Oak Street, Lakewood. New Jersey, 08701 {dagger}Hazleton Laboratories America Incorporated, Vienna, Virginia 22180

Received December 7, 1988; accepted May 25, 1989

Tulobuterol hydrochloride (HCl) has ß2-adrenergic agonist activity and is under development for use in the treatment of chronic obstructive lung disease. The purpose of this study was to determine the toxicity of inhaled tulobuterol HCl in rats and dogs. Rats were whole-body exposed to aerosol gravimetric concentrations of 0, 0.03, 0.22, or 1.1 mg/ liter of tulobuterol HCl, 60 min/day for 28 days. Dogs were exposed (via insufflation) to estimated daily doses of 0, 0.2, 1.0, or 6.0 mg/kg for an equal period. Plasma levels of tulobuterol were determined following exposure on Days 1, 8, and 28 using a high-pressure liquid chromato-graphic method developed for this study. Results indicated that plasma tulobuterol levels were highly correlated with tulobuterol doses (p < 0.0001 for rats and dogs). No dose-related changes in body weight food consumption, hematological, or serum chemistry parameters were observed in either species. Anterior nasal cavity lesions were observed by light microscopy in rats exposed to 0.22 and 1.1 mg/liter tulobuterol HCl at an incidence of 14 and 93%, respectively. These lesions involved the nasal septum, turbinates, and/or the dorsolateral wall of the nasal cavity and consisted of suppurative rhinitis and necrosis. The corresponding mean plasma tulobuterol levels on Day 28 in mid- and high-dose rats were approximately 1000 and 15,000 ng/ml. Nasal lesions were not observed in rats allowed to recover for 2 weeks. No gross or microscopic lesions were detected in lungs or other tissues of either species. These results indicate that the insufflation of high doses of tulobuterol HCl aerosol for 1 month was generally without toxicity in dogs and that the local nasal ussue injury observed in rats exposed to high concentrations of aerosolized tulobuterol HCl was reversible.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.